KYMR Kymera Therapeutics, Inc. - Common Stock
Tentang Kymera Therapeutics, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia
KYMR Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
KYMR Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
KYMR Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
- Beli Kuat 10 33,3%
- Beli 16 53,3%
- Tahan 4 13,3%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
22 analis · 2026-08-16Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $-0.62 | $-0.73 | 0.11% |
| 31 Maret 2026 | $-0.71 | $-0.90 | 0.19% |
| 31 Des. 2025 | $-0.97 | $-0.81 | -0.16% |
| 30 Sep. 2025 | $-0.94 | $-0.82 | -0.12% |
| 30 Juni 2025 | $-0.95 | $-0.83 | -0.12% |
| 31 Maret 2025 | $-0.82 | $-0.93 | 0.11% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| KYMR | $6.33B | -21.1 | -16.7% | -794.0% | -24.4% | — |
| CYTK | $7.81B | -9.7 | 376.6% | -891.6% | 152.7% | — |
| PRAX | $7.43B | -21.9 | 249.5% | — | -47.3% | — |
| SMMT | $13.56B | -12.1 | — | — | -235.1% | — |
| PTGX | $5.47B | -42.6 | -89.4% | -282.8% | -20.3% | — |
| APGE | $5.16B | -17.9 | — | — | — | — |
| KRYS | $7.20B | 36.0 | 33.9% | 52.6% | 18.1% | — |
| IONS | $12.92B | -33.2 | — | — | -68.1% | — |
| SYRE | $2.56B | 10.1 | -62.0% | — | -26.5% | — |
| IMVT | $5.07B | -9.0 | 229.2% | — | -73.7% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 15
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $39M | $47M | $79M | $47M | $73M | $34M | $3M | |
| Cost of Revenue | $39M | $47M | $79M | $47M | · | · | · | |
| R&D Expense | $317M | $240M | $189M | $164M | $137M | $62M | $37M | |
| SG&A Expense | $68M | $64M | $55M | $44M | $36M | $18M | $8M | |
| Operating Expenses | $389M | $309M | $244M | $208M | $173M | $80M | $45M | |
| Operating Income | $-349M | $-262M | $-166M | $-161M | $-101M | $-46M | $-42M | |
| Other Non-op | $38M | $38M | $19M | $6M | $313.0K | $711.0K | $959.0K | |
| Pretax Income | $-311M | · | · | · | · | · | · | |
| Income Tax | $0 | · | · | $0 | $0 | $0 | $0 | |
| Net Income | $-311M | $-224M | $-147M | $-155M | $-100M | $-46M | $-41M | |
| EPS (Basic) | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 | $-3.15 | · | |
| EPS (Diluted) | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 | $-3.15 | · | |
| Shares (Basic) | 84,490,585 | 75,043,991 | 58,365,499 | 53,933,229 | 47,989,023 | 17,349,582 | · | |
| Shares (Diluted) | 84,490,585 | 75,043,991 | 58,365,499 | 53,933,229 | 47,989,023 | 17,349,582 | · | |
| EBITDA | $-341M | $-254M | $-162M | $-158M | $-98M | $-45M | · |
Neraca 21
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $357M | $120M | $110M | $68M | $48M | $31M | $76M | |
| Receivables | $0 | $0 | $15M | $0 | · | · | · | |
| Prepaid Expense | $23M | $22M | $12M | $10M | $9M | $5M | $888.0K | |
| Current Assets | $871M | $510M | $405M | $419M | $451M | $302M | $93M | |
| PP&E (Net) | $43M | $50M | $48M | $13M | $12M | $11M | $4M | |
| PP&E (Gross) | $65M | $67M | $59M | $20M | $16M | $13M | $5M | |
| Accum. Depreciation | $22M | $16M | $10M | $7M | $4M | $2M | $1M | |
| Other Non-current Assets | $9M | $2M | $2M | $3M | $2M | $30.0K | $2M | |
| Total Assets | $1.74B | $978M | $576M | $603M | $606M | $487M | $117M | |
| Accounts Payable | $4M | $6M | $7M | $4M | $4M | $4M | $3M | |
| Accrued Liabilities | $42M | $35M | $34M | $28M | $23M | $10M | $5M | |
| Current Liabilities | $83M | $68M | $86M | $71M | $93M | $111M | $35M | |
| Capital Leases | $67M | $72M | $77M | $12M | $13M | $14M | $17M | |
| Other Non-current Liabilities | · | $0 | $0 | $248.0K | $66.0K | $100.0K | · | |
| Total Liabilities | $163M | $142M | $181M | $113M | $146M | $203M | $82M | |
| Common Stock | $8.0K | $7.0K | $6.0K | $6.0K | $5.0K | $4.0K | · | |
| Retained Earnings | $-1.07B | $-755M | $-531M | $-384M | $-229M | $-129M | $-76M | |
| AOCI | $2M | $-1M | $-552.0K | $-5M | $-660.0K | $-128.0K | $6.0K | |
| Stockholders' Equity | $1.58B | $836M | $395M | $490M | $460M | $284M | $-74M | |
| Liabilities + Equity | $1.74B | $978M | $576M | $603M | $606M | $487M | $117M | |
| Shares Outstanding | 81,323,532 | 64,890,193 | 55,585,305 | 55,039,380 | 51,536,181 | 44,482,186 | 1,929,516 |
Arus Kas 9
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $7M | $4M | $3M | $2M | $2M | $825.0K | |
| Stock-based Comp | $60M | $55M | $43M | $35M | $25M | $5M | $1M | |
| Other Non-cash | $10M | $-33M | $-3M | $-37M | $-56M | $127M | · | |
| Operating Cash Flow | $-233M | $-195M | $-103M | $-153M | $-129M | $88M | $18M | |
| CapEx | $1M | $13M | $34M | $3M | $2M | $9M | $532.0K | |
| Investing Cash Flow | $-521M | $-404M | $140M | $21M | $-100M | $-423M | $-16M | |
| Financing Cash Flow | $991M | $609M | $4M | $153M | $250M | $289M | $35M | |
| Net Change in Cash | $237M | $10M | $41M | $20M | $21M | $-45M | $36M | |
| Free Cash Flow | $-234M | $-207M | $-137M | $-156M | $-131M | $79M | · |
Profitabilitas 7
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -891.1% | -555.8% | -210.6% | -344.4% | -138.0% | -136.1% | · | |
| Net Margin | -794.0% | -475.6% | -187.0% | -330.6% | -137.6% | -134.0% | · | |
| Pretax Margin | -794.0% | · | · | · | · | · | · | |
| EBITDA Margin | -869.9% | -540.2% | -206.1% | -338.0% | -134.7% | -130.9% | · | |
| ROA | -22.9% | -28.8% | -24.9% | -25.6% | -18.3% | -15.1% | · | |
| ROE | -24.4% | -25.9% | -37.2% | -30.9% | -21.3% | -15.8% | · | |
| ROIC | -22.1% | · | · | · | · | · | · |
Likuiditas & Solvabilitas 2
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.5 | 7.5 | 4.7 | 5.9 | 4.9 | 2.7 | · | |
| Quick Ratio | 4.3 | 1.8 | 1.5 | 1.0 | 0.5 | 0.3 | · |
Efisiensi 2
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | · | |
| Receivables Turnover | · | 6.3 | 10.5 | · | · | · | · |
Tingkat Pertumbuhan 3
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -16.7% | -40.1% | 67.8% | -35.7% | 114.0% | · | · | |
| Revenue CAGR 3Y | -5.7% | -13.5% | 32.2% | · | · | · | · | |
| Revenue CAGR 5Y | 2.9% | · | · | · | · | · | · |
Valuasi (TTM) 10
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $39M | $47M | $79M | $47M | $73M | $34M | · | |
| Net Income TTM | $-311M | $-224M | $-147M | $-155M | $-100M | $-46M | · | |
| Market Cap | $6.33B | $2.61B | · | $1.37B | $3.27B | $2.76B | · | |
| P/E | -21.1 | -13.5 | -10.1 | -8.7 | -30.4 | -19.7 | · | |
| P/S | 161.4 | 55.5 | · | 29.3 | 44.9 | 81.0 | · | |
| P/B | 4.0 | 3.1 | · | 2.8 | 7.1 | 9.7 | · | |
| P / Tangible Book | 4.0 | 3.1 | · | 2.8 | 7.1 | 9.7 | · | |
| P / Cash Flow | -27.2 | -13.4 | · | -9.0 | -25.4 | 31.3 | · | |
| P / FCF | -27.0 | -12.6 | · | -8.8 | -25.1 | 34.9 | · | |
| Earnings Yield | -4.7% | -7.4% | -9.9% | -11.5% | -3.3% | -5.1% | · |
Laporan Laba Rugi 14
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65M | $34M | $3M | $3M | $11M | $22M | $7M | $4M | $26M | $10M | $48M | $5M | $17M | $9M | $16M | $10M | |
| Cost of Revenue | $65M | $34M | $3M | $3M | $11M | $22M | $7M | $4M | $26M | $10M | · | · | · | · | · | · | |
| R&D Expense | $119M | $98M | $84M | $74M | $78M | $80M | $72M | $60M | $59M | $49M | $53M | $48M | $46M | $42M | $43M | $44M | |
| SG&A Expense | $21M | $20M | $17M | $17M | $18M | $16M | $16M | $15M | $17M | $14M | $14M | $14M | $14M | $13M | $12M | $11M | |
| Operating Expenses | $141M | $119M | $101M | $95M | $96M | $97M | $88M | $76M | $77M | $68M | $67M | $62M | $60M | $55M | $55M | $54M | |
| Operating Income | $-76M | $-84M | $-98M | $-93M | $-85M | $-74M | $-81M | $-72M | $-51M | $-58M | $-19M | $-58M | $-43M | $-45M | $-39M | $-45M | |
| Other Non-op | $14M | $15M | $11M | $10M | $8M | $9M | $10M | $10M | $9M | $9M | $5M | $5M | $5M | $4M | $4M | $2M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | $100.0K | $100.0K | $0 | · | $0 | |
| Net Income | $-61M | $-69M | $-87M | $-82M | $-77M | $-66M | $-71M | $-62M | $-42M | $-49M | $-14M | $-53M | $-39M | $-41M | $-35M | $-43M | |
| EPS (Basic) | $-0.62 | $-0.71 | $-0.98 | $-0.94 | $-0.95 | $-0.82 | $-0.89 | $-0.82 | $-0.58 | $-0.69 | $-0.25 | $-0.90 | $-0.67 | $-0.70 | $-0.59 | $-0.79 | |
| EPS (Diluted) | $-0.62 | $-0.71 | $-0.98 | $-0.94 | $-0.95 | $-0.82 | $-0.89 | $-0.82 | $-0.58 | $-0.69 | $-0.25 | $-0.90 | $-0.67 | $-0.70 | $-0.59 | $-0.79 | |
| Shares (Basic) | 98,177,158 | 97,534,269 | -163,405,637 | 87,300,286 | 80,449,405 | 80,146,531 | -144,911,702 | 76,125,975 | 73,059,398 | 70,770,320 | -116,570,361 | 58,421,859 | 58,326,963 | 58,187,038 | -104,025,850 | 54,535,514 | |
| Shares (Diluted) | 98,177,158 | 97,534,269 | -163,405,637 | 87,300,286 | 80,449,405 | 80,146,531 | -144,911,702 | 76,125,975 | 73,059,398 | 70,770,320 | -116,570,361 | 58,421,859 | 58,326,963 | 58,187,038 | -104,025,850 | 54,535,514 | |
| EBITDA | $-76M | $-82M | · | $-93M | $-85M | $-72M | · | $-72M | $-51M | $-56M | · | $-58M | $-43M | $-44M | · | $-45M |
Neraca 21
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $124M | $144M | $357M | $113M | $336M | $90M | $120M | $111M | $68M | $94M | $110M | $81M | $52M | $50M | $68M | $156M | |
| Receivables | $20M | · | · | · | $40M | · | · | $0 | $0 | $0 | · | · | · | · | · | · | |
| Prepaid Expense | $26M | $27M | $23M | $23M | $23M | $18M | $22M | $17M | $14M | $15M | · | $14M | $14M | $11M | · | $9M | |
| Current Assets | $737M | $677M | $871M | $528M | $728M | $501M | $510M | $569M | $525M | $537M | · | $376M | $385M | $412M | · | $494M | |
| PP&E (Net) | $40M | $42M | $43M | $45M | $49M | $49M | $50M | $51M | $52M | $49M | · | $36M | $27M | $17M | · | $13M | |
| PP&E (Gross) | $66M | $66M | $65M | $67M | $69M | $67M | $67M | $65M | $64M | $60M | · | $46M | $36M | $25M | · | $19M | |
| Accum. Depreciation | $26M | $24M | $22M | $22M | $20M | $18M | $16M | $14M | $12M | $11M | · | $10M | $9M | $8M | · | $6M | |
| Other Non-current Assets | $7M | $8M | $9M | $7M | $5M | $3M | $2M | $0 | $2M | $2M | · | $3M | $3M | $3M | · | $3M | |
| Total Assets | $1.65B | $1.67B | $1.74B | $1.10B | $1.13B | $918M | $978M | $1.03B | $826M | $868M | · | $552M | $582M | $614M | · | $638M | |
| Accounts Payable | $9M | $13M | $4M | $6M | $6M | $10M | $6M | $6M | $7M | $7M | · | $5M | $4M | $6M | · | $6M | |
| Accrued Liabilities | $48M | $35M | $42M | $29M | $28M | $23M | $35M | $27M | $24M | $16M | · | $26M | $22M | $19M | · | $25M | |
| Current Liabilities | $71M | $63M | $83M | $72M | $88M | $59M | $68M | $67M | $62M | $56M | · | $63M | $55M | $62M | · | $91M | |
| Capital Leases | $64M | $66M | $67M | $68M | $70M | $71M | $72M | $74M | $75M | $76M | · | $77M | $71M | $64M | · | $12M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $8.0K | $230.0K | $237.0K | · | $256.0K | |
| Total Liabilities | $136M | $129M | $163M | $156M | $160M | $132M | $142M | $142M | $141M | $157M | · | $157M | $147M | $152M | · | $126M | |
| Common Stock | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Retained Earnings | $-1.20B | $-1.14B | $-1.07B | $-979M | $-897M | $-820M | $-755M | $-684M | $-621M | $-579M | · | $-516M | $-464M | $-425M | · | $-349M | |
| AOCI | $-7M | $-4M | $2M | $2M | $279.0K | $-58.0K | $-1M | $2M | $-2M | $-2M | · | $-2M | $-4M | $-3M | · | $-6M | |
| Stockholders' Equity | $1.51B | $1.54B | $1.58B | $946M | $971M | $786M | $836M | $893M | $685M | $711M | $395M | $396M | $435M | $462M | $490M | $513M | |
| Liabilities + Equity | $1.65B | $1.67B | $1.74B | $1.10B | $1.13B | $918M | $978M | $1.03B | $826M | $868M | · | $552M | $582M | $614M | · | $638M | |
| Shares Outstanding | 82,788,253 | 82,182,101 | 81,323,532 | 71,741,174 | 70,557,442 | 65,112,714 | 64,890,193 | 64,748,226 | 61,572,383 | 61,353,146 | · | 55,450,239 | 55,390,259 | 55,276,226 | · | 54,751,429 |
Arus Kas 9
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $891.0K | $895.0K | $900.0K | $879.0K | $818.0K | $767.0K | |
| Stock-based Comp | $19M | $16M | $14M | $16M | $15M | $14M | $14M | $15M | $14M | $12M | $11M | $12M | $11M | $9M | $9M | $9M | |
| Other Non-cash | · | $-38M | · | · | · | $-30M | · | · | · | $-4M | · | · | · | $-13M | · | · | |
| Operating Cash Flow | $-54M | $-89M | $-67M | $-27M | $-60M | $-79M | $-62M | $-50M | $-43M | $-40M | $8M | $-32M | $-35M | $-44M | $-40M | $-34M | |
| CapEx | $473.0K | $434.0K | $106.0K | $181.0K | $695.0K | $467.0K | $936.0K | $-189.0K | $5M | $7M | $12M | $8M | $11M | $4M | $373.0K | $1M | |
| Investing Cash Flow | $20M | $-143M | $-394M | $-235M | $60M | $49M | $69M | $-158M | $16M | $-331M | $19M | $61M | $36M | $25M | $-50M | $-37M | |
| Financing Cash Flow | $14M | $19M | $705M | $40M | $246M | $258.0K | $3M | $251M | $1M | $354M | $2M | $-206.0K | $1M | $1M | $2M | $150M | |
| Net Change in Cash | $-20M | $-213M | $244M | $-223M | $246M | $-30M | $10M | $43M | $-26M | $-16M | $29M | $29M | $2M | $-18M | $-87M | $79M | |
| Free Cash Flow | · | $-89M | · | · | · | $-80M | · | · | · | $-47M | · | · | · | $-48M | · | · |
Profitabilitas 5
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -116.3% | -244.9% | · | -3347.4% | -736.8% | -336.8% | · | -1927.9% | -198.5% | -562.2% | · | -1216.4% | -262.7% | -478.8% | · | -469.9% | |
| Net Margin | -94.2% | -201.5% | · | -2973.0% | -667.6% | -296.8% | · | -1670.3% | -164.0% | -472.0% | · | -1118.2% | -235.0% | -432.4% | · | -450.2% | |
| EBITDA Margin | -116.3% | -239.0% | · | -3347.4% | -736.8% | -327.5% | · | -1927.9% | -198.5% | -548.0% | · | -1216.4% | -262.7% | -469.5% | · | -469.9% | |
| ROA | -4.4% | -5.3% | · | -7.7% | -7.8% | -7.3% | · | -7.9% | -6.0% | -6.6% | · | -8.9% | -7.0% | -7.0% | · | -6.7% | |
| ROE | -4.9% | -5.9% | · | -8.9% | -9.2% | -8.8% | · | -9.7% | -7.5% | -8.3% | · | -11.6% | -9.3% | -9.2% | · | -8.6% |
Likuiditas & Solvabilitas 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.3 | 10.8 | · | 7.4 | 8.3 | 8.5 | · | 8.5 | 8.5 | 9.6 | · | 5.9 | 7.1 | 6.6 | · | 5.4 | |
| Quick Ratio | 2.0 | 2.3 | · | 1.6 | 4.3 | 1.5 | · | 1.7 | 1.1 | 1.7 | · | 1.3 | 1.0 | 0.8 | · | 1.7 |
Efisiensi 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 2.2 | · | · | · | 0.6 | · | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM) 10
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $114M | $71M | · | $40M | $63M | $62M | · | $44M | $57M | $41M | · | $40M | $47M | $40M | · | $51M | |
| Net Income TTM | $-289M | $-294M | · | $-287M | $-247M | $-219M | · | $-206M | $-182M | $-181M | · | $-176M | $-163M | $-161M | · | $-149M | |
| Market Cap | $9.49B | $6.84B | · | $4.06B | $3.08B | $1.78B | · | $3.06B | $1.84B | $2.47B | · | $771M | $1.27B | $1.64B | · | $1.19B | |
| P/E | -35.6 | -24.4 | · | -16.0 | -13.8 | -9.4 | · | -15.8 | -10.5 | -13.6 | · | -4.5 | -7.8 | -9.9 | · | -7.7 | |
| P/S | 83.6 | 96.8 | · | 101.3 | 48.9 | 28.8 | · | 69.0 | 32.1 | 60.2 | · | 19.1 | 27.1 | 40.8 | · | 23.4 | |
| P/B | 6.3 | 4.4 | · | 4.3 | 3.2 | 2.3 | · | 3.4 | 2.7 | 3.5 | · | 1.9 | 2.9 | 3.5 | · | 2.3 | |
| P / Tangible Book | 6.3 | 4.4 | · | 4.3 | 3.2 | 2.3 | · | 3.4 | 2.7 | 3.5 | · | 1.9 | 2.9 | 3.5 | · | 2.3 | |
| P / Cash Flow | · | -77.0 | · | · | · | -22.5 | · | · | · | -62.3 | · | · | · | -37.3 | · | · | |
| P / FCF | · | -76.7 | · | · | · | -22.4 | · | · | · | -52.5 | · | · | · | -34.1 | · | · | |
| Earnings Yield | -2.8% | -4.1% | · | -6.2% | -7.3% | -10.6% | · | -6.3% | -9.5% | -7.4% | · | -22.0% | -12.8% | -10.1% | · | -13.1% |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Pendapatan | $39M | $47M | $79M | $47M | $73M |
| Margin Operasi % | -891.1% | -555.8% | -210.6% | -344.4% | -138.0% |
| Laba Bersih | $-311M | $-224M | $-147M | $-155M | $-100M |
| EPS Dilusian | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 |
Neraca
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rasio Lancar | 10.5 | 7.5 | 4.7 | 5.9 | 4.9 |
| Rasio Cepat | 4.3 | 1.8 | 1.5 | 1.0 | 0.5 |
Arus Kas
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-234M | $-207M | $-137M | $-156M | $-131M |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 306 pengaju · $8.0B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 59 (+13 vs Kuartal sebelumnya) | 23 (-13 vs Kuartal sebelumnya) | 94 (+1 vs Kuartal sebelumnya) | 78 (+5 vs Kuartal sebelumnya) | +5.6M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $992.725.940 | 8.657.242 | 12,48% | Saham |
| FMR LLC | $985.896.654 | 8.597.686 | 12,40% | Saham |
| Avoro Capital Advisors LLC | $857.129.238 | 7.474.747 | 10,78% | Saham |
| BVF INC/IL | $444.008.203 | 3.872.052 | 5,58% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $376.085.378 | 3.279.719 | 4,73% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $343.114.771 | 2.992.193 | 4,31% | Saham |
| Siren, L.L.C. | $336.651.626 | 2.935.830 | 4,23% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $336.255.785 | 2.932.378 | 4,23% | Saham |
| Atlas Venture Life Science Advisors, LLC | $326.527.526 | 2.847.541 | 4,11% | Saham |
| STATE STREET CORP | $313.877.705 | 2.737.226 | 3,95% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $181.558.708 | 1.582.987 | 2,28% | Saham |
| Capital Research Global Investors | $159.262.984 | 1.388.881 | 2,00% | Saham |
| Driehaus Capital Management LLC | $105.408.448 | 919.233 | 1,33% | Saham |
| GOLDMAN SACHS GROUP INC | $101.597.391 | 885.998 | 1,28% | Saham |
| Merck & Co., Inc. | $88.544.161 | 772.165 | 1,11% | Saham |
| NORGES BANK | $86.833.399 | 757.246 | 1,09% | Saham |
| FEDERATED HERMES, INC. | $85.933.469 | 749.398 | 1,08% | Saham |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $84.955.104 | 740.866 | 1,07% | Saham |
| ALLIANCEBERNSTEIN L.P. | $81.750.884 | 981.521 | 1,03% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $77.152.155 | 672.819 | 0,97% | Saham |
| Holocene Advisors, LP | $72.996.514 | 636.579 | 0,92% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $60.744.024 | 529.729 | 0,76% | Saham |
| EVENTIDE ASSET MANAGEMENT, LLC | $57.811.287 | 504.210 | 0,73% | Saham |
| JENNISON ASSOCIATES LLC | $57.676.487 | 502.978 | 0,73% | Saham |
| Woodline Partners LP | $57.434.534 | 500.868 | 0,72% | Saham |
| Rock Springs Capital Management LP | $51.963.399 | 453.156 | 0,65% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $51.570.654 | 449.731 | 0,65% | Saham |
| Boxer Capital Management, LLC | $49.204.897 | 429.100 | 0,62% | Saham |
| Pictet Asset Management Holding SA | $44.984.008 | 395.540 | 0,57% | Saham |
| BRAIDWELL LP | $43.363.951 | 378.163 | 0,55% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $43.100.784 | 375.868 | 0,54% | Saham |
| TWO SIGMA INVESTMENTS, LP | $42.585.457 | 371.374 | 0,54% | Saham |
| Clearbridge Investments, LLC | $39.815.871 | 347.221 | 0,50% | Saham |
| Octagon Capital Advisors LP | $35.547.700 | 310.000 | 0,45% | Saham |
| Nextech Invest Ltd. | $31.981.004 | 278.896 | 0,40% | Saham |
| Alyeska Investment Group, L.P. | $31.701.095 | 276.455 | 0,40% | Saham |
| TD Asset Management Inc | $31.293.443 | 272.900 | 0,39% | Saham |
| TWO SIGMA ADVISERS, LP | $29.085.378 | 373.800 | 0,37% | Saham |
| Commodore Capital LP | $28.667.500 | 250.000 | 0,36% | Saham |
| RTW INVESTMENTS, LP | $27.520.800 | 240.000 | 0,35% | Saham |
| GILDER GAGNON HOWE & CO LLC | $26.265.508 | 229.053 | 0,33% | Saham |
| Polar Capital Holdings Plc | $23.363.668 | 203.747 | 0,29% | Saham |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $22.934.000 | 200.000 | 0,29% | Saham |
| Candriam S.C.A. | $22.096.270 | 192.880 | 0,28% | Saham |
| BANK OF AMERICA CORP /DE/ | $21.627.335 | 188.605 | 0,27% | Saham |
| Eagle Health Investments LP | $19.052.191 | 166.148 | 0,24% | Saham |
| Connor, Clark & Lunn Investment Management Ltd. | $17.189.950 | 149.908 | 0,22% | Saham |
| DIADEMA PARTNERS LP | $17.166.099 | 149.700 | 0,22% | Opsi beli |
| Foresite Capital Management VI LLC | $16.779.890 | 146.332 | 0,21% | Saham |
| WCM INVESTMENT MANAGEMENT, LLC | $16.595.869 | 151.810 | 0,21% | Saham |
| JANE STREET GROUP, LLC | $15.732.724 | 137.200 | 0,20% | Opsi beli |
| Deer Management Co. LLC | $14.436.380 | 125.895 | 0,18% | Saham |
| TimesSquare Capital Management, LLC | $14.063.183 | 168.846 | 0,18% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $13.794.801 | 120.300 | 0,17% | Opsi beli |
| Caption Management, LLC | $13.760.400 | 120.000 | 0,17% | Opsi jual |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $13.703.409 | 119.503 | 0,17% | Saham |
| BOONE CAPITAL MANAGEMENT LLC | $12.977.548 | 113.173 | 0,16% | Saham |
| ARMISTICE CAPITAL, LLC | $12.186.210 | 106.272 | 0,15% | Saham |
| First Turn Management, LLC | $11.757.459 | 102.533 | 0,15% | Saham |
| Ensign Peak Advisors, Inc | $11.198.672 | 97.660 | 0,14% | Saham |
| Squarepoint Ops LLC | $11.144.663 | 97.189 | 0,14% | Saham |
| Swiss National Bank | $10.331.767 | 90.100 | 0,13% | Saham |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $10.262.276 | 89.494 | 0,13% | Saham |
| Bank of New York Mellon Corp | $9.823.664 | 85.669 | 0,12% | Saham |
| RHUMBLINE ADVISERS | $9.252.017 | 80.684 | 0,12% | Saham |
| JPMORGAN CHASE & CO | $9.149.756 | 81.205 | 0,12% | Saham |
| Burkehill Global Management, LP | $8.600.250 | 75.000 | 0,11% | Saham |
| VICTORY CAPITAL MANAGEMENT INC | $8.524.567 | 74.340 | 0,11% | Saham |
| CITIGROUP INC | $8.504.959 | 74.169 | 0,11% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $8.462.646 | 73.800 | 0,11% | Opsi jual |
| CITADEL ADVISORS LLC | $8.328.253 | 72.628 | 0,10% | Saham |
| FIFTH THIRD BANCORP | $7.529.104 | 65.659 | 0,09% | Saham |
| BlackRock, Inc. | $7.486.231 | 65.285 | 0,09% | Saham |
| Yiheng Capital Management, L.P. | $7.274.665 | 63.440 | 0,09% | Saham |
| XTX Topco Ltd | $7.052.320 | 61.501 | 0,09% | Saham |
| FIRST TRUST ADVISORS LP | $7.037.068 | 61.368 | 0,09% | Saham |
| Atika Capital Management LLC | $6.957.488 | 60.674 | 0,09% | Saham |
| Nicholas Investment Partners, LP | $6.257.427 | 54.569 | 0,08% | Saham |
| Ikarian Capital, LLC | $5.779.368 | 50.400 | 0,07% | Opsi jual |
| Patient Square Capital LP | $5.446.825 | 47.500 | 0,07% | Saham |
| VANGUARD ASSET MANAGEMENT, Ltd | $5.250.281 | 45.786 | 0,07% | Saham |
| PEREGRINE CAPITAL MANAGEMENT LLC | $5.237.094 | 45.671 | 0,07% | Saham |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $4.687.728 | 56.282 | 0,06% | Saham |
| UBS Group AG | $4.678.880 | 40.803 | 0,06% | Saham |
| AXA Investment Managers S.A. | $4.558.224 | 80.534 | 0,06% | Saham |
| VOYA INVESTMENT MANAGEMENT LLC | $4.451.260 | 38.818 | 0,06% | Saham |
| MARSHALL WACE, LLP | $4.273.177 | 37.265 | 0,05% | Saham |
| STATE OF WISCONSIN INVESTMENT BOARD | $4.223.640 | 36.833 | 0,05% | Saham |
| MetLife Investment Management, LLC | $4.184.767 | 36.494 | 0,05% | Saham |
| Rafferty Asset Management, LLC | $4.046.360 | 35.287 | 0,05% | Saham |
| Odyssean, LLC | $3.954.395 | 34.485 | 0,05% | Saham |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $3.851.880 | 33.591 | 0,05% | Saham |
| CITADEL ADVISORS LLC | $3.841.445 | 33.500 | 0,05% | Opsi jual |
| Aquilo Capital Management, LLC | $3.791.320 | 138.521 | 0,05% | Saham |
| Nan Fung Group Holdings Ltd | $3.540.436 | 30.875 | 0,04% | Saham |
| Moody Aldrich Partners LLC | $3.440.788 | 30.006 | 0,04% | Saham |
| SEVEN GRAND MANAGERS, LLC | $3.440.100 | 30.000 | 0,04% | Saham |
| 683 Capital Management, LLC | $3.440.100 | 30.000 | 0,04% | Opsi jual |
| CITADEL ADVISORS LLC | $3.428.633 | 29.900 | 0,04% | Opsi beli |
| NEW YORK STATE COMMON RETIREMENT FUND | $3.300.203 | 28.780 | 0,04% | Saham |
Orang dalam perusahaan 24 orang dalam · 10 pejabat · 13 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Nello Mainolfi | Chief Executive Officer | 7 Juli 2026 M | 666.568 | 0 | 21 | $-34.875.625 |
| Bruce N. Jacobs | Chief Financial Officer | 30 Juni 2026 M | 244.883 | 0 | 16 | $-13.917.105 |
| Jeremy G Chadwick | Chief Operating Officer | 27 Mei 2026 S | 44.018 | 0 | 29 | $-15.599.618 |
| Terence Rooney | Chief Medical Officer | 27 Juli 2026 A | 38.000 | 0 | 0 | $0 |
| Noah Goodman | Chief Business Officer | 1 Juli 2026 S | 47.179 | 0 | 9 | $-2.223.845 |
| Jared Gollob | Chief Medical Officer | 2 Maret 2026 A | 117.134 | 0 | 18 | $-9.134.491 |
| Brian Adams | Chief Legal Officer | 2 Maret 2026 A | 56.625 | 0 | 0 | $0 |
| Ellen Chiniara | Chief Legal Officer | 3 Maret 2025 A | 80.085 | 0 | 0 | $0 |
| Elaine Caughey | Chief Business Officer | 1 Maret 2023 A | 18.986 | 0 | 0 | $0 |
| Richard Chesworth | Chief Scientific Officer | 27 Agu 2021 M | 0 | 0 | 0 | $0 |
| Bruce Booth | Direktur | 29 Juni 2026 S | 462.856 | 0 | 137 | $-195.559.433 |
| Hrustanovic Gorjan | Direktur | 24 Juni 2026 A | — | 0 | 0 | $0 |
| Elena Ridloff | Direktur | 24 Juni 2026 A | 0 | 0 | 4 | $-1.285.644 |
| Pamela Esposito | Direktur | 24 Juni 2026 A | 1.000 | 0 | 12 | $-3.054.174 |
| Jeffrey W. Albers | Direktur | 24 Juni 2026 A | 0 | 0 | 3 | $-744.757 |
| Victor Sandor | Direktur | 24 Juni 2026 A | — | 0 | 0 | $0 |
| John Maraganore | Direktur | 24 Juni 2026 A | — | 0 | 0 | $0 |
| Leigh Morgan | Direktur | 18 Juni 2024 A | — | 0 | 0 | $0 |
| Joanna Horobin | Direktur | 7 Juni 2024 M | 0 | 0 | 0 | $0 |
| Donald William Nicholson | Direktur | 15 Juni 2022 A | — | 0 | 0 | $0 |
| Steven Edward Hall | Direktur | 25 Agu 2020 C | 2.192.249 | 0 | 0 | $0 |
| Andrew Hedin | Direktur | 20 Agu 2020 A | — | 0 | 0 | $0 |
| Atlas Venture Fund X, L.P. | Pemilik 10% | 18 Mei 2021 J | 5.763.012 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Pemilik 10% | 25 Agu 2020 C | 959.211 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 4 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF PARTNERS L P/IL, BVF INC/IL, LAMPERT MARK N, Hrustanovic Gorjan ×2 pengajuan | 26 Juni 2026 | 6,30% | Amandemen | — | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker ×4 pengajuan | 11 Des. 2025 | 10,90% | Amandemen | Struktur modal | SEC |
| BIOTECHNOLOGY VALUE FUND, L.P., BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II, L.P., BVF II GP LLC, BIOTECHNOLOGY VALUE TRADING FUND OS, L.P., BVF PARTNERS OS LTD., BVF GP HOLDINGS LLC, BVF PARTNERS L.P., BVF INC., MARK N. LAMPERT, GORJAN HRUSTANOVIC ×5 pengajuan | 9 Jan. 2024 | — | Pengajuan awal | — | SEC |
| Vertex Pharmaceuticals Incorporated ×2 pengajuan | 5 Juni 2023 | — | Pengajuan awal | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 64 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 4,23% | 84.154 NS | 31 Mei 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1,99% | 10.000 NS | 31 Mei 2026 | N-PORT |
| HAPS · Harbor ETF Trust | 1,76% | 34.157 NS | 30 April 2026 | N-PORT |
| GURU · Global X Funds | 1,04% | 7.506 NS | 30 April 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,93% | 59.553 NS | 30 April 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,67% | 3.077 NS | 30 April 2026 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,50% | 3.204 NS | 31 Mei 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,39% | 24.697 NS | 30 April 2026 | N-PORT |
| BIB · ProShares Trust | 0,33% | 3.017 NS | 31 Mei 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,33% | 1.305 NS | 31 Mei 2026 | N-PORT |
| ESSC · Strategy Shares | 0,31% | 979 NS | 30 April 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,23% | 20.749 NS | 30 April 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,19% | 1.938 NS | 30 April 2026 | N-PORT |
| RSSL · Global X Funds | 0,14% | 24.820 NS | 30 April 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,13% | 21.796 NS | 30 April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,12% | 2.699 NS | 31 Mei 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,11% | 6.792 NS | 30 April 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,11% | 294.706 NS | 31 Mei 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,08% | 143.695 NS | 30 April 2026 | N-PORT |
| UWM · ProShares Trust | 0,07% | 2.111 NS | 31 Mei 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,06% | 21.910 NS | 30 April 2026 | N-PORT |
| URTY · ProShares Trust | 0,05% | 2.136 NS | 31 Mei 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,05% | 61 NS | 31 Mei 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 5.327 NS | 31 Mei 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,03% | 1.604 NS | 31 Mei 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,02% | 2.239 NS | 31 Mei 2026 | N-PORT |
| HDG · ProShares Trust | 0,02% | 54 NS | 31 Mei 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 93.115 NS | 30 April 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 19.514 NS | 31 Mei 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 675 NS | 30 April 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 2.916 NS | 30 April 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 4.219 NS | 30 April 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,01% | 11.875 NS | 30 April 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,01% | 35.740 NS | 31 Mei 2026 | N-PORT |
| AVLC · AMERICAN CENTURY ETF TRUST | 0,01% | 904 NS | 31 Mei 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 8.494 NS | 30 April 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 3.346 NS | 31 Mei 2026 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | -0,07% | -18.601 NS | 30 April 2026 | N-PORT |
| CLSE · Trust for Professional Managers | -0,15% | -11.041 NS | 31 Mei 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 Juli 2026 | Harian |
| VB · VANGUARD INDEX FUNDS | — | — | 15 Juli 2026 | Harian |
| VBK · VANGUARD INDEX FUNDS | — | — | 15 Juli 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 Juli 2026 | Harian |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 30 Juli 2026 | Harian |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | — | — | 15 Juli 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| ITOT · iShares Trust | — | — | 5 Agu 2026 | Harian |